INTRODUCTION
Type 2 Diabetes Mellitus (DM) is considered as one of the major public health problem resulting in premature mortality and morbidity [1] . Similarly, low Vitamin D levels constitute a largely unrecognized problem in many populations and its global prevalence has been estimated from 30 to 87 % [2] . DM is a metabolic disease which can affect multiorgans in the body and recently vitamin D has aroused widespread interest in the pathogenesis of DM. Over the last five years, a number of large observational studies have suggested an association between DM type-2 and vitamin D deficiency [3, 4] . Vitamin D levels have been documented to have significant inverse relationship with hyperglycemia [5] . Data from various studies on different populations regarding frequency of vitamin D deficiency in newly diagnosed cases of DM type-2 is showing a significant variation of 30% to 70% [6, 7] .
Vitamin D has a well-known role in calcium homeostasis and bone metabolism. The suboptimal levels of vitamin D may contribute to many conditions including rickets, osteomalacia, osteoporosis, falls and fractures. In addition, epidemiologic observations have associated low vitamin D status with an increased risk of non-musculoskeletal diseases, such as cancer, multiple sclerosis and cardiovascular diseases apart from being a risk for developing DM and diabetic complications [8, 9] .
Over many years, links between vitamin D status and diabetes mellitus have been identified. As early as the 1980s [10] , it was shown that vitamin D deficiency in rodents and rabbits inhibits pancreatic insulin secretion, indicating that vitamin D is essential for the function of the endocrine pancreas. Later, the connection between vitamin D and diabetes was reinforced by the discovery of the VDR (Vitamin D Receptor) and DBP (Vitamin D Binding Protein) in pancreatic tissue (more specifically in the insulin-producing b cells) and also in various cell types of the immune system. Thus, vitamin D has been proposed as a possible therapeutic agent in the prevention and treatment of T1D and T2D [11] .
Vitamin D status is defined by measuring the level of 25 hydroxy-cholecalciferol [25(OH) D 3 ] in the blood owing to its longer half-life in plasma. There are different views regarding recommended levels of 25(OH) D 3 , however in latest reviews it has been suggested that a serum concentration of less than 25 nmol/L must be considered as vitamin D deficiency, having varied musculoskeletal and systemic effects. The aim of our study is to find out frequency of vitamin D deficiency in newly diagnosed patients of type 2 DM in our setup in comparison with healthy age and gender matched controls. This study will clarify the variations in our targeted population and also record its frequency in newly diagnosed type 2 DM cases and its correlation with hyperglycemia. This study will further be helpful in timely management of vitamin D deficiency associated morbidity.
MATERIALS AND METHODS
This prospective case control study was conducted in the department of medicine, Pakistan Navy Ship (PNS) Shifa Hospital Karachi from January to December 2015. A total of 302 study subjects were selected after approval of the institutional ethical committee. Out of which 151 newly diagnosed type 2 diabetes cases [on the basis of American Diabetic Association (ADA) criteria] from Medical Out Patient Department (OPD) of the Hospital were selected through non probability consecutive sampling. Age and gender matched 151 healthy subjects from general population were identified and selected as controls randomly. Newly diagnosed type 2 DM patients and controls of both genders, between 35 to 65 years of age were included in the study. Already diagnosed old cases of DM and vitamin D deficiency on the basis of history and medical record or those under treatment for vitamin D deficiency were excluded from the study. Informed consent of included patients was taken after explaining the study protocol. All the patients were investigated for serum 25(OH)D 3 measured by electrochemiluminescence immunoassay using Roche Elecsys ® Systems while plasma glucose and HbA1C were estimated by routine methods on Roche Hitachi ® in pathology laboratory of PNS Shifa Hospital. Vitamin D deficiency was defined as serum level of 25(OH)D 3 less than 25 nmol/L while insufficiency from 25 to 50 nmol/L and sufficiency more than 50 nmol/L. The patients were declared as newly diagnosed type 2 DM with HbA1c more than 6.5 % and fasting plasma glucose of more than 7 mmol/L on more than two occasions, one week apart [12] . Correlation between vitamin D deficiency and HbA1C was found to have inverse relationship with significant p value < 0.001 (Fig. 1) . 
DISCUSSION
Pakistani population has high prevalence of type 2 DM [13] . Among the normal healthy individuals of different ages the prevalence of vitamin D deficiency is high [14] . The association of Vitamin D and DM has been described for more than twenty-five years now [15] . Many studies have revealed that vitamin D is related to various aspects of glucose metabolism e.g. improving beta-cell function of pancreas, insulin secretion and insulin sensitivity and its deficiency is one of the important environmental factors leading to hyperglycemia [16, 17] .
In our study, using serum vitamin D levels of less than 25 nmol/L, vitamin D deficiency was found in 38. 
LIMITATION OF THE STUDY
Our study does not clarify exactly whether vitamin D deficiency is due to type 2 DM or vitamin D deficiency has a role in causing hyperglycemia. To better understand the role of vitamin D in the development and progression of type 2 DM, high quality randomized control trials (RCTs) are needed that may find out the exact pathogenesis of vitamin D deficiency in type 2 DM patients.
CONCLUSION
We concluded that the frequency of vitamin D deficiency is high among patients with newly diagnosed type 2 DM with advancing age and more common in females. The association of vitamin D deficiency with poor glycaemic control in Pakistani patients with type 2 DM points towards the possible role of vitamin D supplementation in regulation of glycemic control in these patients. So, it is recommended that every patient who is newly diagnosed with type 2 DM should be screened for vitamin D deficiency and vitamin D supplementation must be given where necessary.
